RU2002135312A - MEANS FOR STRENGTHENING THE GROWTH HORMONE SECRETION - Google Patents
MEANS FOR STRENGTHENING THE GROWTH HORMONE SECRETIONInfo
- Publication number
- RU2002135312A RU2002135312A RU2002135312/04A RU2002135312A RU2002135312A RU 2002135312 A RU2002135312 A RU 2002135312A RU 2002135312/04 A RU2002135312/04 A RU 2002135312/04A RU 2002135312 A RU2002135312 A RU 2002135312A RU 2002135312 A RU2002135312 A RU 2002135312A
- Authority
- RU
- Russia
- Prior art keywords
- group
- compound according
- branched
- linear
- compound
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title claims 5
- 108010051696 Growth Hormone Proteins 0.000 title claims 5
- 239000000122 growth hormone Substances 0.000 title claims 5
- 230000028327 secretion Effects 0.000 title claims 4
- 238000005728 strengthening Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 238000011084 recovery Methods 0.000 claims 2
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 206010053759 Growth retardation Diseases 0.000 claims 1
- 208000008466 Metabolic Disease Diseases 0.000 claims 1
- 230000036823 Plasma Levels Effects 0.000 claims 1
- 208000008425 Protein Deficiency Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002708 enhancing Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 231100000001 growth retardation Toxicity 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Claims (15)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21132600P | 2000-06-13 | 2000-06-13 | |
US60/211326 | 2000-06-13 | ||
US60/211,326 | 2000-06-13 | ||
US23492800P | 2000-09-26 | 2000-09-26 | |
US60/234928 | 2000-09-26 | ||
US60/234,928 | 2000-09-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002135312A true RU2002135312A (en) | 2004-12-10 |
RU2270198C2 RU2270198C2 (en) | 2006-02-20 |
Family
ID=26906052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002135312/04A RU2270198C2 (en) | 2000-06-13 | 2001-06-13 | Agents enhancing growth hormone secretion |
Country Status (30)
Country | Link |
---|---|
US (2) | US6861409B2 (en) |
EP (1) | EP1289951B1 (en) |
JP (2) | JP3522265B2 (en) |
KR (1) | KR100825109B1 (en) |
CN (1) | CN1232507C (en) |
AR (1) | AR029941A1 (en) |
AT (3) | ATE302181T1 (en) |
AU (2) | AU6606601A (en) |
BG (3) | BG66130B1 (en) |
BR (1) | BRPI0111591B8 (en) |
CA (1) | CA2407659C (en) |
CY (2) | CY1107710T1 (en) |
CZ (2) | CZ303173B6 (en) |
DE (3) | DE60112753T2 (en) |
DK (3) | DK1289951T3 (en) |
ES (3) | ES2250416T3 (en) |
FR (1) | FR19C1044I2 (en) |
HK (1) | HK1054224A1 (en) |
HU (1) | HU229233B1 (en) |
IL (2) | IL153067A0 (en) |
MX (1) | MXPA02011899A (en) |
NL (1) | NL300999I2 (en) |
NO (1) | NO323873B1 (en) |
NZ (1) | NZ522280A (en) |
PL (1) | PL216676B1 (en) |
PT (2) | PT1524272E (en) |
RU (1) | RU2270198C2 (en) |
SK (1) | SK287169B6 (en) |
TW (2) | TWI305529B (en) |
WO (1) | WO2001096300A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60112753T2 (en) * | 2000-06-13 | 2006-06-29 | Zentaris Gmbh | CONNECTIONS TO STIMULATE THE SECRETION OF GROWTH HORMONES |
CU23157A1 (en) * | 2001-01-03 | 2006-07-18 | Ct Ingenieria Genetica Biotech | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TISSULAR DANE DUE TO LACK OF BLOOD IRRIGATION ARTERIAL |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7034050B2 (en) * | 2004-04-28 | 2006-04-25 | Romano Deghenghi | Pseudopeptides growth hormone secretagogues |
JP4879265B2 (en) * | 2005-07-22 | 2012-02-22 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | Growth hormone secretagogue |
EP1757290A1 (en) | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
GB0603295D0 (en) | 2006-02-18 | 2006-03-29 | Ardana Bioscience Ltd | Methods and kits |
CU23558A1 (en) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE |
US7763707B2 (en) * | 2006-03-13 | 2010-07-27 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
CN101657436A (en) | 2007-02-09 | 2010-02-24 | 特兰齐姆制药公司 | Macrocyclic ghrelin receptor modulators and using method thereof |
EP2103602A1 (en) | 2008-03-17 | 2009-09-23 | AEterna Zentaris GmbH | Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
US8431642B2 (en) * | 2008-06-09 | 2013-04-30 | Exxonmobil Chemical Patents Inc. | Polyolefin adhesive compositions and articles made therefrom |
EP2431035A1 (en) | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors |
US9198889B2 (en) | 2012-09-19 | 2015-12-01 | Quality IP Holdings, LLC | Methods for treating post-traumatic stress disorder |
US8747922B2 (en) | 2012-09-19 | 2014-06-10 | Quality Ip Holdings, Inc. | Methods and compositions for increasing sex steroids and growth hormones |
US10300101B2 (en) | 2012-09-19 | 2019-05-28 | Quality IP Holdings, LLC | Methods and compositions for enhancing or maintaining fertility |
US8747921B2 (en) | 2012-09-19 | 2014-06-10 | Quality Ip Holdings, Inc. | Methods for improving health in humans |
US8747923B2 (en) | 2012-09-20 | 2014-06-10 | Quality Ip Holdings, Inc. | Methods for improving health in canines |
US10292957B2 (en) | 2012-09-20 | 2019-05-21 | Quality IP Holdings, LLC | Compositions and methods for treating fibromyalgia |
US8715752B2 (en) | 2012-09-20 | 2014-05-06 | Quality Ip Holdings, Inc. | Compositions for increasing human growth hormone levels |
US9066953B2 (en) | 2012-09-20 | 2015-06-30 | Quality IP Holdings, LLC | Methods for increasing endurance and fat metabolism in humans |
JP6262661B2 (en) | 2012-10-24 | 2018-01-17 | 第一三共株式会社 | A therapeutic agent for amyotrophic lateral sclerosis |
CN105330720A (en) * | 2014-06-06 | 2016-02-17 | 深圳翰宇药业股份有限公司 | Method for preparing macimorelin |
KR102385669B1 (en) | 2015-09-21 | 2022-04-13 | 암모네트 파마 엘엘씨 | Detection and treatment of growth hormone deficiency |
US10894072B2 (en) | 2017-02-13 | 2021-01-19 | IP Quality Holdings, LLC | Compositions and methods for treating fibromyalgia |
US10288629B1 (en) | 2017-12-19 | 2019-05-14 | Aeterna Zentaris, Inc. | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition |
MX2023000935A (en) | 2020-07-22 | 2023-02-22 | Aeterna Zentaris Gmbh | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU637316B2 (en) * | 1988-01-28 | 1993-05-27 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
US5536814A (en) * | 1993-09-27 | 1996-07-16 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
JPH09505601A (en) * | 1993-11-24 | 1997-06-03 | メルク エンド カンパニー インコーポレーテッド | Indolyl-containing compounds and their use to promote growth hormone release |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
US6025471A (en) * | 1998-06-03 | 2000-02-15 | Deghenghi; Romano | Diazaspiro, azepino and azabicyclo therapeutic peptides |
DE60112753T2 (en) * | 2000-06-13 | 2006-06-29 | Zentaris Gmbh | CONNECTIONS TO STIMULATE THE SECRETION OF GROWTH HORMONES |
-
2001
- 2001-06-13 DE DE60112753T patent/DE60112753T2/en not_active Expired - Lifetime
- 2001-06-13 BR BRPI0111591A patent/BRPI0111591B8/en not_active IP Right Cessation
- 2001-06-13 NZ NZ522280A patent/NZ522280A/en not_active IP Right Cessation
- 2001-06-13 DK DK01943504T patent/DK1289951T3/en active
- 2001-06-13 AT AT01943504T patent/ATE302181T1/en active
- 2001-06-13 DK DK03075950T patent/DK1344773T3/en active
- 2001-06-13 AT AT03075950T patent/ATE370119T1/en active
- 2001-06-13 CZ CZ20024095A patent/CZ303173B6/en not_active IP Right Cessation
- 2001-06-13 MX MXPA02011899A patent/MXPA02011899A/en active IP Right Grant
- 2001-06-13 CA CA2407659A patent/CA2407659C/en not_active Expired - Lifetime
- 2001-06-13 IL IL15306701A patent/IL153067A0/en unknown
- 2001-06-13 KR KR1020027016614A patent/KR100825109B1/en active IP Right Grant
- 2001-06-13 PT PT05075086T patent/PT1524272E/en unknown
- 2001-06-13 DE DE60130025T patent/DE60130025T2/en not_active Expired - Lifetime
- 2001-06-13 RU RU2002135312/04A patent/RU2270198C2/en not_active IP Right Cessation
- 2001-06-13 AT AT05075086T patent/ATE362472T1/en active
- 2001-06-13 JP JP2002510444A patent/JP3522265B2/en not_active Expired - Lifetime
- 2001-06-13 AR ARP010102827A patent/AR029941A1/en active IP Right Grant
- 2001-06-13 CN CNB018104916A patent/CN1232507C/en not_active Expired - Lifetime
- 2001-06-13 HU HU0302026A patent/HU229233B1/en active IP Right Revival
- 2001-06-13 ES ES01943504T patent/ES2250416T3/en not_active Expired - Lifetime
- 2001-06-13 AU AU6606601A patent/AU6606601A/en active Pending
- 2001-06-13 DK DK05075086T patent/DK1524272T3/en active
- 2001-06-13 WO PCT/EP2001/006717 patent/WO2001096300A1/en active IP Right Grant
- 2001-06-13 PL PL363081A patent/PL216676B1/en unknown
- 2001-06-13 CZ CZ2011-585A patent/CZ305279B6/en not_active IP Right Cessation
- 2001-06-13 EP EP01943504A patent/EP1289951B1/en not_active Expired - Lifetime
- 2001-06-13 ES ES03075950T patent/ES2292900T3/en not_active Expired - Lifetime
- 2001-06-13 PT PT03075950T patent/PT1344773E/en unknown
- 2001-06-13 ES ES05075086T patent/ES2288724T3/en not_active Expired - Lifetime
- 2001-06-13 SK SK1756-2002A patent/SK287169B6/en not_active IP Right Cessation
- 2001-06-13 DE DE60128494T patent/DE60128494T2/en not_active Expired - Lifetime
- 2001-06-13 AU AU2001266066A patent/AU2001266066B2/en not_active Expired
- 2001-06-13 US US09/880,498 patent/US6861409B2/en not_active Expired - Lifetime
- 2001-08-01 TW TW090114317A patent/TWI305529B/en not_active IP Right Cessation
- 2001-08-01 TW TW097111056A patent/TW200831076A/en unknown
-
2002
- 2002-11-24 IL IL153067A patent/IL153067A/en active IP Right Grant
- 2002-12-09 NO NO20025893A patent/NO323873B1/en not_active IP Right Cessation
- 2002-12-12 BG BG107379A patent/BG66130B1/en unknown
-
2003
- 2003-06-02 JP JP2003156884A patent/JP4932132B2/en not_active Expired - Lifetime
- 2003-08-27 HK HK03106131A patent/HK1054224A1/en not_active IP Right Cessation
-
2004
- 2004-05-04 US US10/837,620 patent/US7297681B2/en not_active Expired - Lifetime
-
2007
- 2007-08-07 CY CY20071101051T patent/CY1107710T1/en unknown
- 2007-11-08 CY CY20071101443T patent/CY1107793T1/en unknown
-
2010
- 2010-07-21 BG BG10110708A patent/BG66216B1/en unknown
- 2010-10-18 BG BG10110771A patent/BG66217B1/en unknown
-
2019
- 2019-07-05 NL NL300999C patent/NL300999I2/en unknown
- 2019-07-08 FR FR19C1044C patent/FR19C1044I2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002135312A (en) | MEANS FOR STRENGTHENING THE GROWTH HORMONE SECRETION | |
CA2407659A1 (en) | Growth hormone secretagogues | |
NO991700L (en) | Benzimidazole-2-carbamates for the treatment of viral infections and cancer | |
JP2003335752A5 (en) | ||
MXPA04009784A (en) | Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors. | |
RU2009114159A (en) | N-METHYLAMINOMETHYLISIDOID COMPOUNDS, COMPOSITIONS INCLUDING THEM, AND WAYS OF THEIR APPLICATION | |
TW200642685A (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
RU97115713A (en) | COMPOUNDS CONTAINING PETROPYRANES AND METHOD OF APPLICATION | |
UA73115C2 (en) | Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency | |
RU2000129161A (en) | DERIVATIVE 1 - [(1-SUBSTITUTED-4-PIPERIDINYL) METHYL] -4-PIPERIDINE, METHOD FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUND, AND THE INTERMEDIATE PRODUCT | |
RU98120057A (en) | D-PROLINE DERIVATIVES | |
DE60307607D1 (en) | USE OF SELECTIVE EP4 RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASES | |
JP2002527474A5 (en) | Medications for the treatment of mania and bipolar disorder | |
RU2008129723A (en) | CCR9 ACTIVITY INHIBITORS | |
RU95113148A (en) | Derivative of 2-(2-amino-1,6-dihydro-6-oxopurine-9-yl)-methoxy- -1,3-propanediol | |
JP2002519425A5 (en) | ||
JP2002503714A5 (en) | ||
DE69428325T2 (en) | Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for inhibiting angiogenesis and angiogenic diseases | |
ATE79257T1 (en) | USE OF TETRAHYDROBENZENE(C,D>INDOL-6CARBOXAMIDES IN THE MANUFACTURE OF PHARMACEUTICALS FOR THE TREATMENT OF ANXIETY CONDITIONS. | |
RU2002101622A (en) | Naphthoquinone derivatives and their use for the treatment and control of tuberculosis | |
DE60035429D1 (en) | USE OF SULFODE HYDROABETIC ACIDS FOR THE TREATMENT OF INFLAMMATORY ENDURANCE | |
RU2003130644A (en) | RARCARBOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AGAINST DIPRESSION AND FEAR | |
ES2053668T3 (en) | POLYAMINE DERIVATIVES AS ANTINEOPLASIC AGENTS. | |
IL159241A0 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
RU2013113301A (en) | SUBSTITUTED 2-OXO- AND 2-THIOXO-DIHYDROCHINOLIN-3-CARBOXAMIDES AS KCNQ2 / 3 MODULATORS |